Generation of donor-specific immunotolerance in renal-allograft recipients
The kidney cannot be successfully grafted without immunosuppressive therapy. A unicenter retrospective study has evaluated the efficiency of immunosuppression with daclizumab (Zenapax) versus alemtuzumab (Campath).Subjects and methods. After renal allotransplantation, 64 patients, including 34 and 3...
Main Authors: | V. A. Goryainov, M. M. Kaabak, M. M. Morozova, L. A. Shishlo, N. N. Babenko, A. K. Zokoyev |
---|---|
Format: | Article |
Language: | English |
Published: |
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
2018-08-01
|
Series: | Трансплантология (Москва) |
Subjects: | |
Online Access: | https://www.jtransplantologiya.ru/jour/article/view/240 |
Similar Items
-
Anemia in renal allograft recipients
by: V. A. Goryainov, et al.
Published: (2018-08-01) -
The effect of the applied induction immunosuppressive therapy protocol on the allografted kidney condition
by: V. A. Goryaynov, et al.
Published: (2017-03-01) -
The impact of С4d deposits in peritubular capillars on living related donor kidney transplantation outcome
by: V. A. Goryaynov, et al.
Published: (2016-03-01) -
The use of belatacept in kidney transplantation
by: N. N. Babenko, et al.
Published: (2018-09-01) -
Bacterial respiratory tract infections in renal allograft recipients
by: A. R. Dostiyev, et al.
Published: (2018-08-01)